Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314

被引:0
|
作者
Kimbria J. Blake
Pankaj Baral
Tiphaine Voisin
Ashira Lubkin
Felipe Almeida Pinho-Ribeiro
Kelsey L. Adams
David P. Roberson
Yuxin C. Ma
Michael Otto
Clifford J. Woolf
Victor J. Torres
Isaac M. Chiu
机构
[1] Division of Immunology,Department of Microbiology and Immunobiology
[2] Harvard Medical School,Department of Microbiology
[3] New York University School of Medicine,Department of Neurobiology
[4] Harvard Medical School,undefined
[5] F.M. Kirby Neurobiology Center,undefined
[6] Boston Children’s Hospital,undefined
[7] Pathogen Molecular Genetics Section,undefined
[8] Laboratory of Bacteriology,undefined
[9] National Institute of Allergy and Infectious Disease,undefined
[10] National Institutes of Health,undefined
来源
Nature Communications | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The hallmark of many bacterial infections is pain. The underlying mechanisms of pain during live pathogen invasion are not well understood. Here, we elucidate key molecular mechanisms of pain produced during live methicillin-resistant Staphylococcus aureus (MRSA) infection. We show that spontaneous pain is dependent on the virulence determinant agr and bacterial pore-forming toxins (PFTs). The cation channel, TRPV1, mediated heat hyperalgesia as a distinct pain modality. Three classes of PFTs—alpha-hemolysin (Hla), phenol-soluble modulins (PSMs), and the leukocidin HlgAB—directly induced neuronal firing and produced spontaneous pain. From these mechanisms, we hypothesized that pores formed in neurons would allow entry of the membrane-impermeable sodium channel blocker QX-314 into nociceptors to silence pain during infection. QX-314 induced immediate and long-lasting blockade of pain caused by MRSA infection, significantly more than lidocaine or ibuprofen, two widely used clinical analgesic treatments.
引用
收藏
相关论文
共 16 条
  • [11] Quaternary Lidocaine Derivative QX-314 Activates and Permeates Human TRPV1 and TRPA1 to Produce Inhibition of Sodium Channels and Cytotoxicity
    Stueber, Thomas
    Eberhardt, Mirjam J.
    Hadamitzky, Christoph
    Jangra, Annette
    Schenk, Stefan
    Dick, Felicia
    Stoetzer, Carsten
    Kistner, Katrin
    Reeh, Peter W.
    Binshtok, Alexander M.
    Leffler, Andreas
    ANESTHESIOLOGY, 2016, 124 (05) : 1153 - 1165
  • [12] Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus
    Zhang, QingFeng
    Jiang, TingTing
    Mao, Xinrui
    Kim, Jae Deog
    Ahn, Dong Ho
    Jung, Yunjin
    Bae, Taeok
    Lee, Bok Luel
    INFECTION AND IMMUNITY, 2021, 89 (10)
  • [13] Antigenic landscapes on Staphylococcus aureus pore-forming toxins reveal insights into specificity and cross-neutralization
    Kailasan, Shweta
    Kant, Ravi
    Noonan-Shueh, Madeleine
    Kanipakala, Tulasikumari
    Liao, Grant
    Shulenin, Sergey
    Leung, Daisy W.
    Alm, Richard A.
    Adhikari, Rajan P.
    Amarasinghe, Gaya K.
    Gross, Michael L.
    Aman, M. Javad
    MABS, 2022, 14 (01)
  • [14] QX-314抑制细菌穿孔毒素和神经元TRPV1介导的金黄色葡萄球菌引发的疼痛
    Blake KJ
    Baral P
    Voisin T
    贾欣
    中国疼痛医学杂志, 2019, 25 (03) : 163 - 166
  • [15] The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins
    Pédelacq, JD
    Maveyraud, L
    Prévost, G
    Baba-Moussa, L
    González, A
    Courcelle, E
    Shepard, W
    Monteil, H
    Samama, JP
    Mourey, L
    STRUCTURE, 1999, 7 (03) : 277 - 287
  • [16] Systemic QX-314 Reduces Bone Cancer Pain through Selective Inhibition of Transient Receptor Potential Vanilloid Subfamily 1-expressing Primary Afferents in Mice
    Fuseya, Satoshi
    Yamamoto, Katsumi
    Minemura, Hitoshi
    Yamaori, Satoshi
    Kawamata, Tomoyuki
    Kawamata, Mikito
    ANESTHESIOLOGY, 2016, 125 (01) : 204 - 218